Florid Lobular Carcinoma In Situ: Imaging Characteristics and Pathologic Upgrade Rates on Surgical Excision
The Breast Journal · 2025
DOI: 10.1155/tbj/3580992 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Breast Journal, 2025. Verfasst von Anshumi Desai und 6 weiteren Autor:innen. Beteiligte Einrichtung: DeWitt Daughtry Family Department of Surgery, Division of Surgical Oncology Miami, University of Miami, Miami, Florida, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Carcinoma, Lobular, Breast Carcinoma In Situ. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Florid lobular carcinoma in situ is an uncommon lobular neoplasia variant that is frequently associated with invasive carcinoma. However, there remains a paucity of information to guide management. The authors aimed to study imaging features associated with pathologic upgrade rates for patients with florid lobular carcinoma in situ identified on core biopsy undergoing surgical excision.
Methods
Patients with florid lobular carcinoma in situ on core biopsy were selected from an institutional pathology database. Patients were excluded if pleomorphic lobular carcinoma in situ was also present on core biopsy. Clinical, radiologic, and pathologic features for each case were reviewed focusing on imaging features which led to core biopsy and those associated with pathologic upgrade on surgical excision.
Results
Eighteen cases of florid lobular carcinoma in situ underwent surgical excision. Upgrade rates on surgical excision were higher in cases with suspicious calcifications (8/11, 73%, p = 0.049) compared to those without (1/7, 14.3%) and in cases with larger breast lesions ( p = 0.011). The overall upgrade rate was 50% (9/18), 89% (8/9) with invasive lobular carcinoma and 11% (1/9) with ductal carcinoma in situ. Of the 8 cases with upgrade to invasive lobular carcinoma, 7/8 (87.5%) were Stage I cancers and only 1/8 (12.5%) had macroscopic lymph node involvement and was upgraded to Stage II.
Conclusion
Florid lobular carcinoma in situ on core biopsy had an upgrade rate on surgical excision of 50% overall, with 89% of these cases upgraded to invasive lobular carcinoma. Pathologic upgrade was seen more frequently with suspicious calcifications and larger breast lesions. These findings can help guide surgical management of this uncommon lobular neoplasia variant including planning extent of excision and consideration for lymph node evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- DeWitt Daughtry Family Department of Surgery, Division of Surgical Oncology Miami, University of Miami, Miami, Florida, USA.
- DeWitt Daughtry Family Department of Surgery, Sylvester Comprehensive Cancer Center, Miami, Florida, USA.
- Baptist Hospital of Miami, Department of Pathology, Baptist Health System, Miami, Florida, USA.
- Department of Radiology, University of Miami, Miami, Florida, USA.
- Department of Pathology and Laboratory Medicine, University of Miami, Miami, Florida, USA.
ORCID-Profile: Anshumi Desai, Susan B Kesmodel, Neha Goel, Youley Tjendra
Zitieren
APA
Desai, A., Kesmodel, S. B., Susnik, B., Goel, N., Feliciano, Y., Gomez-Fernandez, C., & Tjendra, Y. (2025). Florid Lobular Carcinoma In Situ: Imaging Characteristics and Pathologic Upgrade Rates on Surgical Excision. The Breast Journal. https://doi.org/10.1155/tbj/3580992
Vancouver
Desai A, Kesmodel SB, Susnik B, Goel N, Feliciano Y, Gomez-Fernandez C, et al. Florid Lobular Carcinoma In Situ: Imaging Characteristics and Pathologic Upgrade Rates on Surgical Excision. The Breast Journal. 2025. doi:10.1155/tbj/3580992
BibTeX
@article{Desai2025,
author = {Desai, Anshumi and Kesmodel, Susan B and Susnik, Barbara and Goel, Neha and Feliciano, Yara and Gomez-Fernandez, Carmen and Tjendra, Youley},
title = {Florid Lobular Carcinoma In Situ: Imaging Characteristics and Pathologic Upgrade Rates on Surgical Excision},
journal = {The Breast Journal},
year = {2025},
doi = {10.1155/tbj/3580992}
}
EUVIMED